Heart_BMJ

Don't spend time checking, get the #latest content straight to your inbox⏰ ow.ly/lbJy50FPLGT

Geographic variation in long-term health outcomes following myocardial infarction in England bit.ly/4r2JU9P

Why has survival after a heart attack improved so substantially in England and Wales over the past 15 years? Professor James Rudd (@jhfrudd) talks with Dr Sharon Ayayo (@ayayo_sharon) about her MINAP analysis—and whether medicines, coronary intervention, or other changes in care best explain the improvement. Paper - bit.ly/4gyM64p 🎧 Apple: apple.co/4qSsvkt 🎧 Spotify: bit.ly/4quRI3W] 🎧 Podbean: bit.ly/4hRfrsW

Around a third of patients don't respond to cardiac resynchronisation therapy. And up to 10% of implants fail to reach the target vessel at all. Conduction system pacing aims to fix both — by recruiting the heart’s own His-Purkinje network instead of working around it. @KennethEllenbo1 (VCU, past president @HRSonline) joins Professor Rudd (@jhfrudd) on the Heart podcast for a primer on conduction system pacing 🎧 🎧 Apple: apple.co/4ePEjPk 🎧 Spotify: bit.ly/4zM5FxM 🎧 Podbean: bit.ly/4ibCjls ▶️ YouTube: bit.ly/4eNn29o 📄 Paper (free to read): bit.ly/4i9PjId #CardioTwitter #EPeeps #MedEd

Benefit–risk of colchicine and spironolactone in acute myocardial infarction: a prespecified generalised pairwise comparisons analysis of the CLEAR trial bit.ly/4uwT1RM

Anticoagulation in patients with low-burden atrial fibrillation: new evidence focusing on device-detected AF In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Paulus Kirchhoff from the University of Hamburg in Germany. They discuss the concept of device-detected atrial fibrillation and how we should approach anticoagulation in this common patient group. If you enjoy the show, please leave us a positive review wherever you get your podcasts. It helps us to reach more people - thanks! Podcast: bit.ly/4atJ8fx Paper: bit.ly/4aZGzlA

Direct transfer to primary percutaneous coronary intervention centres following out-of-hospital cardiac arrest: longer term outcomes and influences on survival heart.bmj.com/content/early/…

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd (@jhfrudd) is joined by Dr Frances Varian (@VarianFrances) from the University of Sheffield, UK. They discuss her insights as a cardiologist and geography graduate working in the NHS with respect to the environmental impact of climate change on our health. Dr Varian is leading the British Cardiovascular Society's Environment and Sustainability Committee. They also explore how cardiovascular care and research both have environmental impacts, and what we can do individually and at the population level to reduce these impacts. Please see the links below for more information. Podcast: bit.ly/3LHE0L1 ESC strategic plan 2023-2028 (includes sustainability): bit.ly/4r7FL46 Clinical trials carbon footprint guidance: bit.ly/4o4kh5y

Cardiac imaging in oncology: the detection of cardiotoxicity In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Kazuaki Negishi from Sydney, Australia. They discuss the optimal use of imaging to detect cardiac effects of cancer therapies. If you enjoy the show, please leave us a positive review wherever you get your podcasts. It helps us to reach more people - thanks! Podcast: bit.ly/4lj2XtC Paper: bit.ly/44mNwtc

Do older patients benefit from heart failure therapies? Discover insights on the management of heart failure with reduced ejection fraction in older adults as @jhfrudd interviews Dr. Elinor Tan from the National University of Singapore. Learn more about the latest research findings on the efficacy and side effects of current therapies in this informative discussion. Read the paper here: bit.ly/3RbVeCM Listen to the interview: bit.ly/4nlMpSY

Myocardial infarction with non-obstructive coronary arteries: a pathway to achieve guideline adherence bit.ly/3Q3SZ3U

Weight loss as a marker of successful decongestion during acute heart failure hospitalisation heart.bmj.com/content/early/…

From risk factor to therapeutic target: obesity therapy and cardiovascular outcomes, and Cardiovascular benefits of obesity therapies: an overview of obesity medicines and metabolic bariatric surgery Editorial and state-of-the-art review below: bit.ly/4leysoK

Benefit–risk of colchicine and spironolactone in acute myocardial infarction: a prespecified generalised pairwise comparisons analysis of the CLEAR trial bit.ly/4uwT1RM

Biological uncertainty cannot be eliminated by diagnostic certainty: the Heisenberg problem of occlusive myocardial infarction bit.ly/4gKw34M

Read this specialist review: Implementing clinical practice guidelines in cardiology: accelerating the translation of evidence into practice bit.ly/4tHWYBV

Use and misuse of composite endpoints in randomised clinical trials bit.ly/46Uqr1P

Cardiopulmonary exercise testing in contemporary cardiology: physiological insights, novel applications and evolving algorithms bit.ly/4c2zQIj

Making sense of composite endpoints: efficiency, meaning and clinical relevance in modern cardiovascular trials bit.ly/4gSs053

Timeless therapeutics: cardiac indications for vitamin K antagonists in clinical practice bit.ly/40j6QW0

Use and misuse of composite endpoints in randomised clinical trials bit.ly/46Uqr1P